Mangoceuticals (MGRX) Income Statement (2022 - 2026)
Income Statement report data from Mar 31, 2022 to Mar 31, 2026 for Mangoceuticals (MGRX).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||
Total Revenue | 70K (-12.50%) | 80K (-52.94%) | 170K (+54.55%) | 110K (-15.38%) | 130K (-18.75%) | 160K (-23.81%) | 210K (-12.50%) | 240K (-4.00%) | 250K (+78.57%) | 140K (+40.00%) | 100K (+900.00%) | 10K | - | - | - |
Cost Of Revenue | 10K | - | 20K (0.00%) | 20K (0.00%) | 20K (-33.33%) | 30K (+50.00%) | 20K (-60.00%) | 50K (0.00%) | 50K (+66.67%) | 30K (+50.00%) | 20K | - | - | - | - |
Costof Goods And Services Sold | 10K | - | 20K (0.00%) | 20K (0.00%) | 20K (-33.33%) | 30K (+50.00%) | 20K (-60.00%) | 50K (0.00%) | 50K (+66.67%) | 30K (+50.00%) | 20K | - | - | - | - |
Gross Profit | 30K (-40.00%) | 50K (-44.44%) | 90K (+50.00%) | 60K (-25.00%) | 80K (+14.29%) | 70K (-53.33%) | 150K (+7.14%) | 140K (0.00%) | 140K (+55.56%) | 90K (+50.00%) | 60K | - | - | - | - |
Operating Expenses | |||||||||||||||
Selling General And Administrative | 1.05M (+238.71%) | 310K (-75.20%) | 1.25M (-18.83%) | 1.54M (+196.15%) | 520K (-38.82%) | 850K (+10.39%) | 770K (-62.98%) | 2.08M (+285.19%) | 540K (-5.26%) | 570K (+338.46%) | 130K (-58.06%) | 310K (-68.69%) | 990K (+200.00%) | 330K (+1550.00%) | 20K |
Operating Expenses | 3.16M (-58.37%) | 7.59M (+41.60%) | 5.36M (+15.52%) | 4.64M (+152.17%) | 1.84M (-17.86%) | 2.24M (-11.11%) | 2.52M (-7.01%) | 2.71M (+39.69%) | 1.94M (-18.49%) | 2.38M (-9.16%) | 2.62M (+296.97%) | 660K (-33.33%) | 990K (+200.00%) | 330K (+1550.00%) | 20K |
Depreciation And Amortization | - | - | - | - | - | - | 10K (-50.00%) | 20K | - | - | 10K | - | - | - | - |
Operating Income | |||||||||||||||
Operating Income | -3.13M (-58.49%) | -7.54M (+43.07%) | -5.27M (+15.07%) | -4.58M (+160.23%) | -1.76M (-18.89%) | -2.17M (-8.44%) | -2.37M (-7.78%) | -2.57M (+42.78%) | -1.80M (-21.40%) | -2.29M (-10.55%) | -2.56M (+293.85%) | -650.00K (-34.34%) | -990.00K (+200.00%) | -330.00K (+1550.00%) | -20.00K |
Ebit | -3.13M (-58.49%) | -7.54M (+43.07%) | -5.27M (+15.07%) | -4.58M (+160.23%) | -1.76M (-18.89%) | -2.17M (-8.44%) | -2.37M (-7.78%) | -2.57M (+42.78%) | -1.80M (-21.40%) | -2.29M (-10.55%) | -2.56M (+293.85%) | -650.00K (-34.34%) | -990.00K (+200.00%) | -330.00K (+1550.00%) | -20.00K |
EBITDA | -3.13M (-58.49%) | -7.54M (+39.89%) | -5.39M (+17.69%) | -4.58M (+129.00%) | -2.00M (-16.32%) | -2.39M (+1.27%) | -2.36M (-7.81%) | -2.56M (+42.22%) | -1.80M (-21.05%) | -2.28M (-10.59%) | -2.55M (+286.36%) | -660.00K (-33.33%) | -990.00K (+219.35%) | -310.00K (+1450.00%) | -20.00K |
Other Income / Expenses | |||||||||||||||
Interest Expense | - | 80K (+300.00%) | 20K | -10.00K | - | - | - | -10.00K | - | - | - | 10K | - | - | - |
Net Interest Income | - | - | - | - | - | - | - | 10K | - | - | - | -10.00K | - | - | - |
Other Non Operating Income | -280.00K (+250.00%) | -80.00K (-46.67%) | -150.00K (-42.31%) | -260.00K (+8.33%) | -240.00K (+9.09%) | -220.00K | - | 10K | - | 10K | - | -10.00K | - | - | - |
Net Income | |||||||||||||||
Income Before Tax | -3.40M (-55.38%) | -7.62M (+40.59%) | -5.42M (+11.98%) | -4.84M (+142.00%) | -2.00M (-16.32%) | -2.39M (+0.84%) | -2.37M (-7.78%) | -2.57M (+42.78%) | -1.80M (-21.05%) | -2.28M (-10.94%) | -2.56M (+293.85%) | -650.00K (-34.34%) | -990.00K (+200.00%) | -330.00K (+1550.00%) | -20.00K |
Net Income From Continuing Operations | -3.40M (-55.38%) | -7.62M (+40.59%) | -5.42M (+11.98%) | -4.84M (+142.00%) | -2.00M (-16.32%) | -2.39M (+0.84%) | -2.37M (-7.78%) | -2.57M (+42.78%) | -1.80M (-21.05%) | -2.28M (-10.94%) | -2.56M (+282.09%) | -670.00K (-32.32%) | -990.00K (+219.35%) | -310.00K (+1450.00%) | -20.00K |
Net Income | -3.40M (-55.38%) | -7.62M (+40.59%) | -5.42M (+11.98%) | -4.84M (+142.00%) | -2.00M (-16.32%) | -2.39M (+0.84%) | -2.37M (-7.78%) | -2.57M (+42.78%) | -1.80M (-21.05%) | -2.28M (-10.94%) | -2.56M (+282.09%) | -670.00K (-32.32%) | -990.00K (+219.35%) | -310.00K (+1450.00%) | -20.00K |
Comprehensive Income Net Of Tax | -3.40M (-55.38%) | -7.62M (+40.59%) | -5.42M (+12.22%) | -4.83M (+141.50%) | -2.00M (-16.32%) | -2.39M (+0.84%) | -2.37M (-74.27%) | -9.21M (+411.67%) | -1.80M (-21.05%) | -2.28M (-10.94%) | -2.56M | - | - | - | - |